Literature DB >> 7592718

Agonist-stimulated cyclic ADP ribose. Endogenous modulator of Ca(2+)-induced Ca2+ release in intestinal longitudinal muscle.

J F Kuemmerle1, G M Makhlouf.   

Abstract

We have previously shown that agonist-induced Ca2+ mobilization in intestinal longitudinal muscle is mediated by ryanodine-sensitive, inositol 1,4,5-trisphosphate-insensitive sacroplasmic Ca2+ channels. Ca2+ release via these channels is triggered by agonist-stimulated Ca2+ influx and results in Ca(2+)-induced Ca2+ release. The present study examined whether cyclic ADP-ribose (cADPR) is synthesized in response to stimulation of longitudinal muscle by agonists and modulates the activity of Ca2+ release channels. Cyclic ADPR bound with high affinity to dispersed longitudinal muscle cells (IC50 1.9nM) and induced Ca2+ release (EC50 3.8 nM), increase in [Ca2+]i (EC50 2.0 nM), and contraction (EC50 1.1 nM); cADPR had no effect on circular muscle cells. The effects of cADPR were blocked by ruthenium red, dantrolene, and the specific antagonist, 8-amino-cADPR, and were augmented by caffeine but not affected by heparin. The binding of cADPR and its ability to stimulate Ca2+ release were dependent on the concentration of Ca2+. Cyclic ADPR was capable of stimulating Ca2+ release at subthreshold Ca2+ concentrations (25-100 nM) and of enhancing Ca(2+)-induced Ca2+ release. Longitudinal muscle extracts incubated with beta-NAD+ produced a time-dependent increase in Ca(2+)-mobilizing activity identified as authentic cADPR by blockade of Ca2+ release with 8-amino-cADPR and ruthenium red. Ca2+ mobilizing activity was increased by cholecystokinin octapeptide (CCK-8) in a concentration-dependent fashion. The increase induced by CCK-8 was suppressed by the CCK-A antagonist, L364,718, nifedipine, and guanyl-5'-yl thiophosphate. The study shows that ADP-ribosyl cyclase can be stimulated by agonists and that cADPR can act as an endogenous modulator of Ca(2+)-induced Ca2+ release.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592718     DOI: 10.1074/jbc.270.43.25488

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Two different but converging messenger pathways to intracellular Ca(2+) release: the roles of nicotinic acid adenine dinucleotide phosphate, cyclic ADP-ribose and inositol trisphosphate.

Authors:  J M Cancela; O V Gerasimenko; J V Gerasimenko; A V Tepikin; O H Petersen
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Novel peptide inhibitor of ecto-ADP-ribosyl cyclase of bone marrow stromal cell antigen-1 (BST-1/CD157).

Authors:  A Sato; S Yamamoto; K Ishihara; T Hirano; H Jingami
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

Review 3.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

4.  Antenatal betamethasone increases vascular reactivity to endothelin-1 by upregulation of CD38/cADPR signaling.

Authors:  J-H Lee; J Zhang; G A Massmann; J P Figueroa
Journal:  J Dev Orig Health Dis       Date:  2014-02       Impact factor: 2.401

Review 5.  Hypoxia and smooth muscle function: key regulatory events during metabolic stress.

Authors:  M J Taggart; S Wray
Journal:  J Physiol       Date:  1998-06-01       Impact factor: 5.182

Review 6.  Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.

Authors:  H C Lee; C Munshi; R Graeff
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

7.  InsP3, but not novel Ca2+ releasers, contributes to agonist-initiated contraction in rabbit airway smooth muscle.

Authors:  K Iizuka; A Yoshii; K Dobashi; T Horie; M Mori; T Nakazawa
Journal:  J Physiol       Date:  1998-09-15       Impact factor: 5.182

Review 8.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Daratumumab induces CD38 internalization and impairs myeloma cell adhesion.

Authors:  Jayeeta Ghose; Domenico Viola; Cesar Terrazas; Enrico Caserta; Estelle Troadec; Jihane Khalife; Emine Gulsen Gunes; James Sanchez; Tinisha McDonald; Guido Marcucci; Balveen Kaur; Michael Rosenzweig; Jonathan Keats; Steven Rosen; Amrita Krishnan; Abhay R Satoskar; Craig C Hofmeister; Flavia Pichiorri
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

10.  Jun kinase-induced overexpression of leukemia-associated Rho GEF (LARG) mediates sustained hypercontraction of longitudinal smooth muscle in inflammation.

Authors:  Othman Al-Shboul; Ancy D Nalli; Divya P Kumar; Ruizhe Zhou; Sunila Mahavadi; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-16       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.